Progression In Glaucoma

Introduction We mark the eighth consecutive year for the World Glaucoma Association Glaucoma Consensus with Consensus VIII. Our topic is the Progression of Glaucoma. Global experts were invited and assembled by our international co-Chairs beginning in January 2011, to participate in the Project Forum E-Room, a unique online opportunity to facilitate discussion of each of the consensus meetings. Participants then were engaged in the discussion of five topical areas to reach consensus on key issues that surround and permeate all aspects of the progression of glaucoma. The results of these thoughtful discussions then were summarized by each of the sections with preliminary consensus statements. The Draft of the Consensus Report, including the preliminary consensus statements, was distributed to the Societies and Partners for review and comments prior to the Consensus Meeting that took place in Paris on Tuesday, June 28, 2011. On this day, relevant stakeholders engaged in a stimulating, educational, and thought-provoking session that highlighted the review and revision of the consensus statements. The Consensus Report then was finalized by Consensus co- Chairs and Editors. Consensus statements were reviewed and finalized by the expert Consensus Panel. Robert N. Weinreb, Editor

This book covers interpretation of visual fields by Humphrey and Octopus perimeters and discussion of Humphrey visual fields in a variety of ocular disorders.It examines dilemmas faced by an ophthalmologist while evaluating visual fields which do not match with the clinical picture. Glaucoma, the commonest condition for visual field investigation is discussed in detail. Logical reasoningfor incorporating perimetry in glaucoma management with a clear understanding of the challenges in its interpretation is delved into. The book progresses to advanced glaucoma and glaucoma progression. It discusses a systematic evaluation of various parts of the visual field so that the reader can make a calculated management plan for their patient. Each chapter attempts to clearly enunciate factors that help in the diagnosis and features which may be confused with other conditions. Fields which help diagnosing early, advanced glaucoma and glaucoma progression with images and methods of ensuring reasonable diagnostic accuracy are included. The book incorporates separate chapters on ocular conditions which also mimic visual field defects of glaucoma with detailed modes of correct diagnosis, diagnostic dilemmas arising from retinal, macular, vascular, visual pathway lesions mimicking visual field defects of glaucoma or while coexisting with glaucoma, supported by algorithms to achieve a quick diagnosis in a busy OPD without missing the clinical findings and by using minimal investigative modalities. This book helps clinicians to prevent over diagnosis or under diagnosis of glaucoma and helps diagnose cases with morbidities causing visual field defects.

Introduction We mark the eighth consecutive year for the World Glaucoma Association Glaucoma Consensus with Consensus VIII. Our topic is the Progression of Glaucoma. Global experts were invited and assembled by our international co-Chairs beginning in January 2011, to participate in the Project Forum E-Room, a unique online opportunity to facilitate discussion of each of the consensus meetings. Participants then were engaged in the discussion of five topical areas to reach consensus on key issues that surround and permeate all aspects of the progression of glaucoma. The results of these thoughtful discussions then were summarized by each of the sections with preliminary consensus statements. The Draft of the Consensus Report, including the preliminary consensus statements, was distributed to the Societies and Partners for review and comments prior to the Consensus Meeting that took place in Paris on Tuesday, June 28, 2011. On this day, relevant stakeholders engaged in a stimulating, educational, and thought-provoking session that highlighted the review and revision of the consensus statements. The Consensus Report then was finalized by Consensus co- Chairs and Editors. Consensus statements were reviewed and finalized by the expert Consensus Panel. Robert N. Weinreb, Editor

Primary Open-Angle Glaucoma was the topic of the tenth World Glaucoma Association Consensus meeting. As with prior meetings, it was a daunting task to seek and obtain consensus on broad subject matter that ranges from diagnosis, risk profiling and screening of the disease. As it is unclear how each of us decides how we practice and the evidence to guide us often is sparse, this consensus, as well as the others, is based not only on the published literature, but also on expert opinion. Although consensus does not replace and is not a surrogate for scientific investigation, it does provide considerable value, especially when the desired evidence is lacking. The goal of this consensus is to provide a foundation for diagnosing and managing primary open-angle glaucoma and how it can be best done in clinical practice. Identification of those areas for which we have little evidence and, therefore, the need for additional research always is a high priority. We hope that this consensus report will serve as a benchmark of our understanding. However, this consensus report is intended to be fluid. It is expected that it will be revised and improved with the emergence of new evidence.

Preface Childhood is the topic of the ninth World Glaucoma Association Consensus. There has been only sparse attention to the diagnosis and treatment of childhood glaucoma. Both pediatric ophthalmologists and glaucoma specialists provide care for such children. In some instances, they manage these individuals alone and, in others, the management is shared. For this consensus, the participation of both groups was solicited. The global faculty, consisting of leading authorities on the clinical and scientific aspects of childhood glaucoma, met in Vancouver on July 16, 2013, just prior to the World Glaucoma Congress, to discuss the reports and refine the consensus statements. As with prior meetings, it was a daunting task to seek and obtain consensus on such a complicated and nuanced subject. It is unclear how each of us decides how we practice, and evidence to guide us often is sparse. It is remarkable how few high level studies have been conducted on the management of childhood glaucoma. Hence, this consensus, as with the others, is based not only on the published literature, but also on expert opinion. Although consensus does not replace and is not a surrogate for scientific investigation, it does provide considerable value, especially when the desired evidence is lacking. The goal of this consensus was to provide a foundation for diagnosing and treating childhood glaucoma and how it can be best done in clinical practice. Identification of those areas for which we have little evidence and, therefore, the need for additional research also was a high priority. We hope that this consensus report will serve as a benchmark of our understanding. However, this consensus report, as with each of the others, is intended to be just a beginning. It is expected that it will be revised and improved with the emergence of new evidence. Robert N. Weinreb, Chair

Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a recent Institute of Medicine study on this important issue, interpreting them for a general audience. Marijuana As Medicine? provides patientsâ€"as well as the people who care for themâ€"with a foundation for making decisions about their own health care. This empowering volume examines several key points, including: Whether marijuana can relieve a variety of symptoms, including pain, muscle spasticity, nausea, and appetite loss. The dangers of smoking marijuana, as well as the effects of its active chemical components on the immune system and on psychological health. The potential use of marijuana-based medications on symptoms of AIDS, cancer, multiple sclerosis, and several other specific disorders, in comparison with existing treatments. Marijuana As Medicine? introduces readers to the active compounds in marijuana. These include the principal ingredient in Marinol, a legal medication. The authors also discuss the prospects for developing other drugs derived from marijuana's active ingredients. In addition to providing an up-to-date review of the science behind the medical marijuana debate, Mack and Joy also answer common questions about the legal status of marijuana, explaining the conflict between state and federal law regarding its medical use. Intended primarily as an aid to patients and caregivers, this book objectively presents critical information so that it can be used to make responsible health care decisions. Marijuana As Medicine? will also be a valuable resource for policymakers, health care providers, patient counselors, medical faculty and studentsâ€"in short, anyone who wants to learn more about this important issue.